Maaz Mohiuddin, MD
Allergy & Immunology · Crest Hill, ILNPI 1720251697
Payments from drug & device makers
Across 871 payments — averaging $87.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$62K
- GSK$3K
- Sanofi$3K
- Novartis$2K
- CSL Behring$848
- Optinose US, Inc.$678
- plus $5K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 207 | $62,015 |
| GSK | 183 | $2,743 |
| Sanofi | 52 | $2,717 |
| Novartis | 127 | $1,926 |
| CSL Behring | 30 | $848 |
| Optinose US, Inc. | 40 | $678 |
| AbbVie | 31 | $602 |
| Regeneron Healthcare Solutions, Inc. | 22 | $583 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $582 |
| Biocryst US Sales Co., LLC | 25 | $530 |
| Amgen(2 entities) | 27 | $505 |
| Octapharma USA, Inc. | 5 | $354 |
| Genentech USA, Inc. | 12 | $270 |
| Teva Pharmaceuticals USA, Inc. | 12 | $247 |
| Pfizer | 13 | $223 |
| Boehringer Ingelheim | 9 | $162 |
| Alk-abello, Inc | 8 | $156 |
| Kaleo, Inc. | 8 | $135 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $118 |
| Grifols USA, LLC | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 1 | $64 |
| Cycle Pharmaceuticals Inc | 2 | $61 |
| Pharming Healthcare, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 3 | $51 |
| Shire North American Group Inc | 2 | $49 |
| Phadia US Inc. | 3 | $41 |
| Lilly USA, LLC | 2 | $39 |
| Merck | 2 | $37 |
| GC Biopharma USA, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Incyte Corporation | 1 | $13 |
| Philips North America LLC | 1 | $12 |
How this compares
$75,982 in reported general payments places this provider in the 85th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Crest Hill
- Dareen SiriNormal$5.9M
- Giselle MosnaimChicago$2.2M
- Anju PetersChicago$2.1M
- Priya BansalSaint Charles$1.3M
- Rachna ShahMelrose Park$1M
- Melanie MakhijaChicago$402K
- Elizabeth LippnerChicago$329K
- Patrick WinShiloh$314K
- Christina CiaccioChicago$310K
- Amanda SalihChicago$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.